Targeting Breast Cancer Cells with G4 PAMAM Dendrimers and Valproic Acid Derivative Complexes

Area of Science:

• Medicinal Chemistry
• Nanotechnology
• Pharmacology

Background:

• Developed Valproic Acid (VPA) derivatives as anti-proliferative agents targeting HDAC8.
• Identified poor water solubility as a limitation for VPA derivatives.

Purpose of the Study:

• Utilized fourth-generation Polyamidoamine (G4 PAMAM) dendrimers as drug carriers.
• Enhanced water solubility and in vitro anti-proliferative efficacy of VPA derivatives.

Main Methods:

• Docking and Molecular Dynamics (MD) simulations to assess VPA-G4 PAMAM interactions.
• HPLC-UV/VIS, 1H NMR, MALDI-TOF, and atomic force microscopy to confirm complex formation.
• In vitro cytotoxicity assays on MDAMB-231, MCF7, and 3T3-L1 cell lines.

Main Results:

• Docking and MD simulations confirmed stable VPA-G4 PAMAM complexes with polar interactions.
• HPLC demonstrated increased water solubility proportional to G4 PAMAM concentration.
• VPA-G4 PAMAM complexes exhibited anti-proliferative effects on cancer cell lines, with varying efficacy.
• G4 PAMAM showed toxicity at micromolar concentrations.

Conclusions:

• G4 PAMAM dendrimers successfully improved water solubility and cytotoxic activity of aryl-VPA derivatives.
• Demonstrated potential for G4 PAMAM dendrimers in drug delivery for cancer therapy.
• Highlighted the importance of formulation for therapeutic efficacy.